Avidity Biosciences Inc (RNA)
52.23
-0.32
(-0.61%)
USD |
NASDAQ |
Nov 14, 10:32
Avidity Biosciences Price to Book Value: 5.010 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 5.041 |
| November 12, 2024 | 4.482 |
| November 11, 2024 | 4.520 |
| November 08, 2024 | 4.481 |
| November 07, 2024 | 4.557 |
| November 06, 2024 | 4.531 |
| November 05, 2024 | 4.325 |
| November 04, 2024 | 4.299 |
| November 01, 2024 | 4.016 |
| October 31, 2024 | 4.054 |
| October 30, 2024 | 4.146 |
| October 29, 2024 | 4.275 |
| October 28, 2024 | 4.385 |
| October 25, 2024 | 4.327 |
| October 24, 2024 | 4.331 |
| October 23, 2024 | 4.355 |
| October 22, 2024 | 4.545 |
| October 21, 2024 | 4.480 |
| October 18, 2024 | 4.839 |
| October 17, 2024 | 4.654 |
| October 16, 2024 | 4.694 |
| October 15, 2024 | 4.480 |
| October 14, 2024 | 4.480 |
| October 11, 2024 | 4.470 |
| October 10, 2024 | 4.242 |
| Date | Value |
|---|---|
| October 09, 2024 | 4.389 |
| October 08, 2024 | 4.444 |
| October 07, 2024 | 4.216 |
| October 04, 2024 | 4.537 |
| October 03, 2024 | 4.513 |
| October 02, 2024 | 4.520 |
| October 01, 2024 | 4.653 |
| September 30, 2024 | 4.406 |
| September 27, 2024 | 4.060 |
| September 26, 2024 | 4.045 |
| September 25, 2024 | 4.408 |
| September 24, 2024 | 4.220 |
| September 23, 2024 | 4.172 |
| September 20, 2024 | 4.266 |
| September 19, 2024 | 4.379 |
| September 18, 2024 | 4.281 |
| September 17, 2024 | 4.047 |
| September 16, 2024 | 4.005 |
| September 13, 2024 | 4.001 |
| September 12, 2024 | 3.962 |
| September 11, 2024 | 3.889 |
| September 10, 2024 | 3.913 |
| September 09, 2024 | 3.910 |
| September 06, 2024 | 3.881 |
| September 05, 2024 | 3.910 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6974
Minimum
Oct 27 2023
17.90
Maximum
Jun 22 2020
2.834
Average
2.798
Median
Apr 14 2021
Price to Book Value Benchmarks
| Sarepta Therapeutics Inc | 8.621 |
| Natera Inc | 23.61 |
| Entrada Therapeutics Inc | 1.738 |
| Alnylam Pharmaceuticals Inc | 1038.50 |
| Catalyst Pharmaceuticals Inc | 3.934 |
Price to Book Value Related Metrics
| PS Ratio | 424.19 |
| Price | 52.23 |
| Earnings Yield | -5.65% |
| Market Cap | 6.117B |